Agency Forms Undergoing Paperwork Reduction Act Review, 73288-73292 [2021-28031]
Download as PDF
<![CDATA[
73288
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
(immediate post-course and delayed
follow-up). This information will
provide helpful feedback for training
improvement. The new tools for CDC
TRAIN were developed based on an
extensive feedback process from
training developers and evaluators and
cognitive testing to refine the questions.
To prepare for the future merger of
TCEO and CDC TRAIN systems, the
content of these tools also include
questions that are required for
accreditation (from the TCEO PostCourse Evaluation and TCEO Follow-Up
Evaluation tools).
Currently in both platforms, data will
be collected online, using secure,
electronic, web-based, passwordprotected portals. Respondents will
include educational developers
requesting accreditation for their
trainings (TCEO) and public health and
healthcare professionals who seek
training (CDC TRAIN and TCEO). No
statistical methods will be used to
analyze the information collected. CDC
will use identifiable information in
TCEO to track participant completion of
educational activities to facilitate
required reporting to earn continuing
education credits, hours, or units.
Aggregate and non-aggregate data from
the evaluations in TCEO and CDC
TRAIN will be used to improve
educational activities and assess
learning outcomes.
Overall, this revision request seeks to
achieve three objectives. First, it will
allow for short-term continuation of the
TCEO system and its ability to serve
individuals seeking accredited training.
The demand for TCEO’s trainings and
accreditation remains high and ongoing.
Second, it will allow for more
standardized evaluation of trainings
offered through CDC TRAIN, based on
the data collection methods and tools
already used successfully in TCEO.
Third, by proposing CDC TRAIN as an
approved platform, it lays a key step for
the eventual discontinuation of the
TCEO platform and incorporation of
TCEO’s trainings and tools into the CDC
TRAIN platform. Future change requests
for this revision likely will involve
additional steps in this merger process,
such as the retirement of TCEO as a
platform, the discontinuation of the
TCEO-specific training evaluation tools
in favor of CDC TRAIN’s forms, and the
absorption of TCEO’s trainings and
other features into the CDC TRAIN
platform. These anticipated changes
should not affect the burden hours or
type of information that learners are
asked to provide. These future changes
should improve learners’ experiences,
through more standardization and
centralization; and they should result in
significant program management
efficiencies for CDC and its training
partners.
OMB approval is requested for three
years. Participation is voluntary and
there are no costs to respondents other
than their time. The total estimated
annualized burden is 288,150 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Type
of respondents
Educational Developers (Health
Public Health and Health Care
(Learners).
Public Health and Health Care
(Learners).
Public Health and Health Care
(Learners).
Public Health and Health Care
(Learners).
Public Health and Health Care
(Learners).
130
300,000
1
1
5
5/60
Professionals
TCEO Post-Course Evaluation ......................
300,000
3
10/60
Professionals
TCEO Follow-up Evaluation ...........................
30,000
3
3/60
Professionals
CDC TRAIN Immediate Post-Course Evaluation Tool.
CDC TRAIN Delayed Follow-Up Evaluation
Tool.
300,000
3
7/60
30,000
3
2/60
Professionals
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–0666]
khammond on DSKJM1Z7X2PROD with NOTICES
Average
burden per
response
(in hours)
TCEO Proposal ..............................................
TCEO New Participant Registration ...............
[FR Doc. 2021–28030 Filed 12–23–21; 8:45 am]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National
Healthcare Safety Network (NHSN) to
19:11 Dec 23, 2021
Number
of responses
per
respondent
Educators) ..
Professionals
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
VerDate Sep<11>2014
Number
of respondents
Form name
Jkt 256001
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on September 27, 2021 to obtain
comments from the public and affected
agencies. CDC received four nonsubstantive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
E:\FR\FM\27DEN1.SGM
27DEN1
73289
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Healthcare Safety Network
(NHSN) (OMB Control No. 0920–0666,
Exp. 12/31/2023)—Revision—National
Center for Emerging and Zoonotic
Infection Diseases (NCEZID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Healthcare Quality
Promotion (DHQP), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC) collects
data from healthcare facilities in the
National Healthcare Safety Network
(NHSN) under OMB Control No. 0920–
0666. NHSN provides facilities, states,
regions, and the nation with data
necessary to identify problem areas,
measure the progress of prevention
efforts, and ultimately eliminate
healthcare-associated infections (HAIs),
nationwide. Additionally, NHSN allows
healthcare facilities to track blood safety
errors and various healthcare-associated
infection prevention practice methods,
such as healthcare personnel influenza
vaccine status and corresponding
infection control adherence rates. NHSN
currently has seven components: Patient
Safety (PS), Healthcare Personnel Safety
(HPS), Biovigilance (BV), Long-Term
Care Facility (LTCF), Outpatient
Procedure (OPC), Dialysis Component,
and the Neonatal Component. NHSN
has increasingly served as the operating
system for HAI reporting compliance
through legislation established by the
states. As of April 2020, 36 states, the
District of Columbia and the City of
Philadelphia, Pennsylvania have opted
to use NHSN as their primary system for
mandated reporting. Reporting
compliance is completed by healthcare
facilities in their respective
jurisdictions, with emphasis on those
states and municipalities acquiring
varying consequences for failure to use
NHSN. Additionally, healthcare
facilities in five U.S. territories (Puerto
Rico, American Samoa, the U.S. Virgin
Islands, Guam, and the Northern
Mariana Islands) are voluntarily
reporting to NHSN. Additional
territories are projected to follow with
similar use of NHSN for reporting
purposes.
NHSN’s data is used to aid in the
tracking of HAIs and guide infection
prevention activities/practices that
protect patients. The Centers for
Medicare and Medicaid Services (CMS),
and other payers use these data to
determine incentives for performance at
healthcare facilities across the US and
surrounding territories. Members of the
public may also use some protected data
to inform their selection among
available providers.
Each of these parties is dependent on
the completeness and accuracy of the
data. CDC and CMS work closely and
are fully committed to ensuring
complete and accurate reporting, which
are critical for protecting patients and
guiding national, state, and local
prevention priorities. CMS collects
some HAI data and healthcare personnel
influenza vaccination summary data,
which is done on a voluntary basis as
part of its Fee-for-Service Medicare
quality reporting programs, while others
may report data required by a federal
mandate. Facilities that fail to report
quality measure data are subject to
partial payment reduction in the
applicable Medicare Fee-for-Service
payment system. CMS links their
quality reporting to payment for
Medicare-eligible acute care hospitals,
inpatient rehabilitation facilities, longterm acute care facilities, oncology
hospitals, inpatient psychiatric
facilities, dialysis facilities, and
ambulatory surgery centers. Facilities
report HAI data and healthcare
personnel influenza vaccination
summary data to CMS via NHSN as part
of CMS’s quality reporting programs to
receive full payment.
Many healthcare facilities, even in
states without HAI reporting legislation,
submit limited HAI data to NHSN
voluntarily. NHSN’s data collection
updates continue to support the
incentive programs managed by CMS.
For example, survey questions support
requirements for CMS’ quality reporting
programs. Additionally, CDC has
collaborated with CMS on a voluntary
National Nursing Home Quality
Collaborative, which focuses on
recruiting nursing homes to report HAI
data to NHSN and to retain their
continued participation.
NHSN was previously approved in
December of 2020 for 5,943,401
responses; 1,321,991 burden hours, and
is due to expire on December 31, 2023.
The proposed changes in this new ICR
include revisions to ten data collection
forms. There are a total of 86 proposed
data collection forms, but no new forms
are being added at this time. The total
estimated burden requested in this
Revision is for 1,584,651 hours.
khammond on DSKJM1Z7X2PROD with NOTICES
ESTIMATED ANNUAL BURDEN
Number of
respondents
Respondent type
Form number & name
U.S. Healthcare Facilities/NHSN Participants
57.100 NHSN Registration Form ...................
57.101 Facility Contact Information ...............
57.103 Patient Safety Component—Annual
Hospital Survey.
57.104 Facility Administrator Change Request Form.
57.105 Group Contact Information ................
57.106 Patient Safety Monthly Reporting
Plan.
57.108 Primary Bloodstream Infection (BSI)
57.111 Pneumonia (PNEU) ...........................
57.112 Ventilator-Associated Event ...............
57.113 Pediatric Ventilator-Associated Event
(PedVAE).
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\27DEN1.SGM
Number of
responses per
respondent
Average
burden per
response
(hour)
2,000
2,000
6,765
1
1
1
5/60
10/60
90/60
800
1
5/60
1,000
7,821
1
12
5/60
15/60
5,775
1,800
5,463
334
5
2
8
1
38/60
30/60
28/60
30/60
27DEN1
73290
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
ESTIMATED ANNUAL BURDEN—Continued
khammond on DSKJM1Z7X2PROD with NOTICES
Respondent type
Number of
respondents
Form number & name
57.114 Urinary Tract Infection (UTI) ..............
57.115 Custom Event ....................................
57.116 Denominators for Neonatal Intensive
Care Unit (NICU).
57.117 Denominators for Specialty Care
Area (SCA)/Oncology (ONC).
57.118 Denominators for Intensive Care Unit
(ICU)/Other locations (not NICU or SCA).
57.120 Surgical Site Infection (SSI) ...............
57.121 Denominator for Procedure ...............
57.122 HAI Progress Report State Health
Department Survey.
57.123 Antimicrobial Use and Resistance
(AUR)-Microbiology
Data
Electronic
Upload Specification Tables.
57.124 Antimicrobial Use and Resistance
(AUR)-Pharmacy Data Electronic Upload
Specification Tables.
57.125 Central Line Insertion Practices Adherence Monitoring.
57.126 MDRO or CDI Infection Form ............
57.127 MDRO and CDI Prevention Process
and Outcome Measures Monthly Monitoring.
57.128 Laboratory-identified MDRO or CDI
Event.
57.129 Adult Sepsis .......................................
57.135 Late Onset Sepsis/Meningitis Denominator Form: Data Table for monthly
electronic upload.
57.136 Late Onset Sepsis/Meningitis Event
Form: Data Table for Monthly Electronic
Upload.
57.137 Long-Term Care Facility Component—Annual Facility Survey.
57.138 Laboratory-identified MDRO or CDI
Event for LTCF.
57.139 MDRO and CDI Prevention Process
Measures Monthly Monitoring for LTCF.
57.140 Urinary Tract Infection (UTI) for LTCF
57.141 Monthly Reporting Plan for LTCF ......
57.142 Denominators for LTCF Locations .....
57.143 Prevention Process Measures Monthly Monitoring for LTCF.
57.150 LTAC Annual Survey .........................
57.151 Rehab Annual Survey ........................
57.200 Healthcare Personnel Safety Component Annual Facility Survey.
57.204 Healthcare Worker Demographic
Data.
57.205 Exposure to Blood/Body Fluids .........
57.206 Healthcare Worker Prophylaxis/Treatment.
57.207 Follow-Up Laboratory Testing ............
57.210 Healthcare Worker Prophylaxis/Treatment-Influenza.
57.300 Hemovigilance Module Annual Survey.
57.301 Hemovigilance Module Monthly Reporting Plan.
57.303 Hemovigilance Module Monthly Reporting Denominators.
57.305 Hemovigilance Incident ......................
57.306 Hemovigilance Module Annual Survey—Non-acute care facility.
57.307 Hemovigilance Adverse Reaction—
Acute Hemolytic Transfusion Reaction.
57.308 Hemovigilance Adverse Reaction—
Allergic Transfusion Reaction.
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(hour)
6,000
600
1,100
5
91
12
20/60
35/60
4/60
500
12
5/60
5,500
60
5/60
6,000
6,000
55
9
602
1
35/60
10/60
28/60
2,500
12
5/60
2,500
12
5/60
500
213
25/60
720
5,500
11
29
30/60
15/60
4,800
79
20/60
50
300
250
6
25/60
5/60
300
6
5/60
17,700
1
120/60
1,998
24
20/60
1,998
12
20/60
339
2,011
339
130
36
12
12
12
35/60
5/60
35/60
5/60
620
1,340
50
1
1
1
82/60
82/60
480/60
50
200
20/60
50
50
50
30
60/60
15/60
50
50
50
50
15/60
10/60
500
1
85/60
500
12
60/60
500
12
70/60
500
500
10
1
10/60
35/60
500
4
20/60
500
4
20/60
E:\FR\FM\27DEN1.SGM
27DEN1
73291
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
ESTIMATED ANNUAL BURDEN—Continued
khammond on DSKJM1Z7X2PROD with NOTICES
Respondent type
Number of
respondents
Form number & name
57.309 Hemovigilance Adverse Reaction—
Delayed Hemolytic Transfusion Reaction.
57.310 Hemovigilance Adverse Reaction—
Delayed Serologic Transfusion Reaction.
57.311 Hemovigilance Adverse Reaction—
Febrile Non-hemolytic Transfusion Reaction.
57.312 Hemovigilance Adverse Reaction—
Hypotensive Transfusion Reaction.
57.313 Hemovigilance Adverse Reaction—
Infection.
57.314 Hemovigilance Adverse Reaction—
Post Transfusion Purpura.
57.315 Hemovigilance Adverse Reaction—
Transfusion Associated Dyspnea.
57.316 Hemovigilance Adverse Reaction—
Transfusion Associated Graft vs. Host Disease.
57.317 Hemovigilance Adverse Reaction—
Transfusion Related Acute Lung Injury.
57.318 Hemovigilance Adverse Reaction—
Transfusion Associated Circulatory Overload.
57.319 Hemovigilance Adverse Reaction—
Unknown Transfusion Reaction.
57.320 Hemovigilance Adverse Reaction—
Other Transfusion Reaction.
57.400 Outpatient Procedure Component—
Annual Facility Survey.
57.401 Outpatient Procedure Component—
Monthly Reporting Plan.
57.402 Outpatient Procedure Component
Same Day Outcome Measures.
57.403 Outpatient Procedure Component—
Monthly Denominators for Same Day Outcome Measures.
57.404 Outpatient Procedure Component—
SSI Denominator.
57.405 Outpatient Procedure Component—
Surgical Site (SSI) Event.
57.500 Outpatient Dialysis Center Practices
Survey.
57.501 Dialysis Monthly Reporting Plan ........
57.502 Dialysis Event ....................................
57.503 Denominator for Outpatient Dialysis ..
57.504 Prevention Process Measures Monthly Monitoring for Dialysis.
57.505 Dialysis Patient Influenza Vaccination
57.506 Dialysis Patient Influenza Vaccination
Denominator.
57.507 Home Dialysis Center Practices Survey.
Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for NonLong-Term Care Facilities.
Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for LongTerm Care Facilities.
Weekly Resident Influenza Vaccination Cumulative Summary for Long-Term Care
Facilities.
Annual Healthcare Personnel Influenza Vaccination Summary.
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\27DEN1.SGM
Number of
responses per
respondent
Average
burden per
response
(hour)
500
1
20/60
500
2
20/60
500
4
20/60
500
1
20/60
500
1
20/60
500
1
20/60
500
1
20/60
500
1
20/60
500
1
20/60
500
2
20/60
500
1
20/60
500
1
20/60
700
1
10/60
700
12
15/60
200
1
40/60
200
400
40/60
700
100
40/60
700
5
40/60
7,200
1
12/60
7,200
7,200
7,200
1,730
12
30
30
12
5/60
25/60
10/60
75/60
615
615
50
5
10/60
10/60
430
1
30/60
125
52
60/60
1,200
52
60/60
2,500
52
60/60
5,000
1
120/60
27DEN1
73292
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–28031 Filed 12–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH or the Advisory
Board). This meeting is open to the
public, buy without a public comment
period. The public is welcome to submit
written comments in advance of the
meeting, to the contact person below.
Written comments received in advance
of the meeting will be included in the
official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the teleconference
(information below). The audio
conference line has 150 ports for callers.
DATES: The meeting will be held on
February 16, 2022, from 11:00 a.m. to
1:00 p.m., EST. Written comments must
be received on or before February 9,
2022.
ADDRESSES: You may submit comments
by mail to: Sherri Diana, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS
C–34, Cincinnati, Ohio 45226. Meeting
Information: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
pass code is 9933701.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone:
(513) 533–6800, Toll Free: 1(800)CDC–
INFO, Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, rechartered on
March 22, 2020, and will terminate on
March 22, 2022.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Considered: The agenda
will include discussions on: Work
Group and Subcommittee Reports;
Update on the Status of SEC Petitions;
and plans for the April 2022 Advisory
Board meeting. Agenda items are subject
to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–28020 Filed 12–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH),
Subcommittee on Procedures Reviews
(SPR), National Institute for
Occupational Safety and Health
(NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Subcommittee on Procedures
Reviews (SPR) of the Advisory Board on
Radiation and Worker Health (ABRWH
or the Advisory Board). This meeting is
open to the public, but without a public
comment period. The public is welcome
to submit written comments in advance
of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included
in the official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the audio conference
(information below). The audio
conference line has 150 ports for callers.
DATES: The meeting will be held on
February 15, 2022, from 11:00 a.m. to
3:30 p.m., EST. Written comments must
be received on or before February 8,
2022.
SUMMARY:
You may submit comments
by mail to: Sherri Diana, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
34, Cincinnati, Ohio 45226.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone:
(513) 533–6800, Toll Free 1 (800) CDC–
INFO, Email: ocas@cdc.gov.
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 86, Number 245 (Monday, December 27, 2021)]
[Notices]
[Pages 73288-73292]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28031]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0666]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Healthcare Safety Network (NHSN) to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on September 27, 2021 to obtain
comments from the public and affected agencies. CDC received four non-
substantive comments related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570.
[[Page 73289]]
Comments and recommendations for the proposed information collection
should be sent within 30 days of publication of this notice to
www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function. Direct written
comments and/or suggestions regarding the items contained in this
notice to the Attention: CDC Desk Officer, Office of Management and
Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Healthcare Safety Network (NHSN) (OMB Control No. 0920-
0666, Exp. 12/31/2023)--Revision--National Center for Emerging and
Zoonotic Infection Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Division of Healthcare Quality Promotion (DHQP), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention (CDC) collects data from healthcare
facilities in the National Healthcare Safety Network (NHSN) under OMB
Control No. 0920-0666. NHSN provides facilities, states, regions, and
the nation with data necessary to identify problem areas, measure the
progress of prevention efforts, and ultimately eliminate healthcare-
associated infections (HAIs), nationwide. Additionally, NHSN allows
healthcare facilities to track blood safety errors and various
healthcare-associated infection prevention practice methods, such as
healthcare personnel influenza vaccine status and corresponding
infection control adherence rates. NHSN currently has seven components:
Patient Safety (PS), Healthcare Personnel Safety (HPS), Biovigilance
(BV), Long-Term Care Facility (LTCF), Outpatient Procedure (OPC),
Dialysis Component, and the Neonatal Component. NHSN has increasingly
served as the operating system for HAI reporting compliance through
legislation established by the states. As of April 2020, 36 states, the
District of Columbia and the City of Philadelphia, Pennsylvania have
opted to use NHSN as their primary system for mandated reporting.
Reporting compliance is completed by healthcare facilities in their
respective jurisdictions, with emphasis on those states and
municipalities acquiring varying consequences for failure to use NHSN.
Additionally, healthcare facilities in five U.S. territories (Puerto
Rico, American Samoa, the U.S. Virgin Islands, Guam, and the Northern
Mariana Islands) are voluntarily reporting to NHSN. Additional
territories are projected to follow with similar use of NHSN for
reporting purposes.
NHSN's data is used to aid in the tracking of HAIs and guide
infection prevention activities/practices that protect patients. The
Centers for Medicare and Medicaid Services (CMS), and other payers use
these data to determine incentives for performance at healthcare
facilities across the US and surrounding territories. Members of the
public may also use some protected data to inform their selection among
available providers.
Each of these parties is dependent on the completeness and accuracy
of the data. CDC and CMS work closely and are fully committed to
ensuring complete and accurate reporting, which are critical for
protecting patients and guiding national, state, and local prevention
priorities. CMS collects some HAI data and healthcare personnel
influenza vaccination summary data, which is done on a voluntary basis
as part of its Fee-for-Service Medicare quality reporting programs,
while others may report data required by a federal mandate. Facilities
that fail to report quality measure data are subject to partial payment
reduction in the applicable Medicare Fee-for-Service payment system.
CMS links their quality reporting to payment for Medicare-eligible
acute care hospitals, inpatient rehabilitation facilities, long-term
acute care facilities, oncology hospitals, inpatient psychiatric
facilities, dialysis facilities, and ambulatory surgery centers.
Facilities report HAI data and healthcare personnel influenza
vaccination summary data to CMS via NHSN as part of CMS's quality
reporting programs to receive full payment.
Many healthcare facilities, even in states without HAI reporting
legislation, submit limited HAI data to NHSN voluntarily. NHSN's data
collection updates continue to support the incentive programs managed
by CMS. For example, survey questions support requirements for CMS'
quality reporting programs. Additionally, CDC has collaborated with CMS
on a voluntary National Nursing Home Quality Collaborative, which
focuses on recruiting nursing homes to report HAI data to NHSN and to
retain their continued participation.
NHSN was previously approved in December of 2020 for 5,943,401
responses; 1,321,991 burden hours, and is due to expire on December 31,
2023. The proposed changes in this new ICR include revisions to ten
data collection forms. There are a total of 86 proposed data collection
forms, but no new forms are being added at this time. The total
estimated burden requested in this Revision is for 1,584,651 hours.
Estimated Annual Burden
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Respondent type Form number & name respondents responses per response
respondent (hour)
----------------------------------------------------------------------------------------------------------------
U.S. Healthcare Facilities/NHSN 57.100 NHSN Registration 2,000 1 5/60
Participants. Form.
57.101 Facility Contact 2,000 1 10/60
Information.
57.103 Patient Safety 6,765 1 90/60
Component--Annual
Hospital Survey.
57.104 Facility 800 1 5/60
Administrator Change
Request Form.
57.105 Group Contact 1,000 1 5/60
Information.
57.106 Patient Safety 7,821 12 15/60
Monthly Reporting Plan.
57.108 Primary 5,775 5 38/60
Bloodstream Infection
(BSI).
57.111 Pneumonia (PNEU). 1,800 2 30/60
57.112 Ventilator- 5,463 8 28/60
Associated Event.
57.113 Pediatric 334 1 30/60
Ventilator-Associated
Event (PedVAE).
[[Page 73290]]
57.114 Urinary Tract 6,000 5 20/60
Infection (UTI).
57.115 Custom Event..... 600 91 35/60
57.116 Denominators for 1,100 12 4/60
Neonatal Intensive Care
Unit (NICU).
57.117 Denominators for 500 12 5/60
Specialty Care Area
(SCA)/Oncology (ONC).
57.118 Denominators for 5,500 60 5/60
Intensive Care Unit
(ICU)/Other locations
(not NICU or SCA).
57.120 Surgical Site 6,000 9 35/60
Infection (SSI).
57.121 Denominator for 6,000 602 10/60
Procedure.
57.122 HAI Progress 55 1 28/60
Report State Health
Department Survey.
57.123 Antimicrobial Use 2,500 12 5/60
and Resistance (AUR)-
Microbiology Data
Electronic Upload
Specification Tables.
57.124 Antimicrobial Use 2,500 12 5/60
and Resistance (AUR)-
Pharmacy Data
Electronic Upload
Specification Tables.
57.125 Central Line 500 213 25/60
Insertion Practices
Adherence Monitoring.
57.126 MDRO or CDI 720 11 30/60
Infection Form.
57.127 MDRO and CDI 5,500 29 15/60
Prevention Process and
Outcome Measures
Monthly Monitoring.
57.128 Laboratory- 4,800 79 20/60
identified MDRO or CDI
Event.
57.129 Adult Sepsis..... 50 250 25/60
57.135 Late Onset Sepsis/ 300 6 5/60
Meningitis Denominator
Form: Data Table for
monthly electronic
upload.
57.136 Late Onset Sepsis/ 300 6 5/60
Meningitis Event Form:
Data Table for Monthly
Electronic Upload.
57.137 Long-Term Care 17,700 1 120/60
Facility Component--
Annual Facility Survey.
57.138 Laboratory- 1,998 24 20/60
identified MDRO or CDI
Event for LTCF.
57.139 MDRO and CDI 1,998 12 20/60
Prevention Process
Measures Monthly
Monitoring for LTCF.
57.140 Urinary Tract 339 36 35/60
Infection (UTI) for
LTCF.
57.141 Monthly Reporting 2,011 12 5/60
Plan for LTCF.
57.142 Denominators for 339 12 35/60
LTCF Locations.
57.143 Prevention 130 12 5/60
Process Measures
Monthly Monitoring for
LTCF.
57.150 LTAC Annual 620 1 82/60
Survey.
57.151 Rehab Annual 1,340 1 82/60
Survey.
57.200 Healthcare 50 1 480/60
Personnel Safety
Component Annual
Facility Survey.
57.204 Healthcare Worker 50 200 20/60
Demographic Data.
57.205 Exposure to Blood/ 50 50 60/60
Body Fluids.
57.206 Healthcare Worker 50 30 15/60
Prophylaxis/Treatment.
57.207 Follow-Up 50 50 15/60
Laboratory Testing.
57.210 Healthcare Worker 50 50 10/60
Prophylaxis/Treatment-
Influenza.
57.300 Hemovigilance 500 1 85/60
Module Annual Survey.
57.301 Hemovigilance 500 12 60/60
Module Monthly
Reporting Plan.
57.303 Hemovigilance 500 12 70/60
Module Monthly
Reporting Denominators.
57.305 Hemovigilance 500 10 10/60
Incident.
57.306 Hemovigilance 500 1 35/60
Module Annual Survey--
Non-acute care facility.
57.307 Hemovigilance 500 4 20/60
Adverse Reaction--Acute
Hemolytic Transfusion
Reaction.
57.308 Hemovigilance 500 4 20/60
Adverse Reaction--
Allergic Transfusion
Reaction.
[[Page 73291]]
57.309 Hemovigilance 500 1 20/60
Adverse Reaction--
Delayed Hemolytic
Transfusion Reaction.
57.310 Hemovigilance 500 2 20/60
Adverse Reaction--
Delayed Serologic
Transfusion Reaction.
57.311 Hemovigilance 500 4 20/60
Adverse Reaction--
Febrile Non-hemolytic
Transfusion Reaction.
57.312 Hemovigilance 500 1 20/60
Adverse Reaction--
Hypotensive Transfusion
Reaction.
57.313 Hemovigilance 500 1 20/60
Adverse Reaction--
Infection.
57.314 Hemovigilance 500 1 20/60
Adverse Reaction--Post
Transfusion Purpura.
57.315 Hemovigilance 500 1 20/60
Adverse Reaction--
Transfusion Associated
Dyspnea.
57.316 Hemovigilance 500 1 20/60
Adverse Reaction--
Transfusion Associated
Graft vs. Host Disease.
57.317 Hemovigilance 500 1 20/60
Adverse Reaction--
Transfusion Related
Acute Lung Injury.
57.318 Hemovigilance 500 2 20/60
Adverse Reaction--
Transfusion Associated
Circulatory Overload.
57.319 Hemovigilance 500 1 20/60
Adverse Reaction--
Unknown Transfusion
Reaction.
57.320 Hemovigilance 500 1 20/60
Adverse Reaction--Other
Transfusion Reaction.
57.400 Outpatient 700 1 10/60
Procedure Component--
Annual Facility Survey.
57.401 Outpatient 700 12 15/60
Procedure Component--
Monthly Reporting Plan.
57.402 Outpatient 200 1 40/60
Procedure Component
Same Day Outcome
Measures.
57.403 Outpatient 200 400 40/60
Procedure Component--
Monthly Denominators
for Same Day Outcome
Measures.
57.404 Outpatient 700 100 40/60
Procedure Component--
SSI Denominator.
57.405 Outpatient 700 5 40/60
Procedure Component--
Surgical Site (SSI)
Event.
57.500 Outpatient 7,200 1 12/60
Dialysis Center
Practices Survey.
57.501 Dialysis Monthly 7,200 12 5/60
Reporting Plan.
57.502 Dialysis Event... 7,200 30 25/60
57.503 Denominator for 7,200 30 10/60
Outpatient Dialysis.
57.504 Prevention 1,730 12 75/60
Process Measures
Monthly Monitoring for
Dialysis.
57.505 Dialysis Patient 615 50 10/60
Influenza Vaccination.
57.506 Dialysis Patient 615 5 10/60
Influenza Vaccination
Denominator.
57.507 Home Dialysis 430 1 30/60
Center Practices Survey.
Weekly Healthcare 125 52 60/60
Personnel Influenza
Vaccination Cumulative
Summary for Non-Long-
Term Care Facilities.
Weekly Healthcare 1,200 52 60/60
Personnel Influenza
Vaccination Cumulative
Summary for Long-Term
Care Facilities.
Weekly Resident 2,500 52 60/60
Influenza Vaccination
Cumulative Summary for
Long-Term Care
Facilities.
Annual Healthcare 5,000 1 120/60
Personnel Influenza
Vaccination Summary.
----------------------------------------------------------------------------------------------------------------
[[Page 73292]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-28031 Filed 12-23-21; 8:45 am]
BILLING CODE 4163-18-P
